As demonstrated by non-invasive bioluminescence imaging in two animals, tumor size remained constant after treatment with 213Bi-anti-CD38-MAb at days 34, 47, and 59 after tumor cell inoculation, whereas it drastically increased in PBS treated mice (Fig. 6B). This evidence concerns the gene CD38 and neoplasm.